Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats
The DOI matches its Crossref record.
Abstract
The pregnancy hormone relaxin elicits renal vasodilation, hyperfiltration, and osmoregulatory changes when chronically administered to conscious, nonpregnant rats. The objective in this study was to determine the dose response and time course of hormone action, as well as the time required for recovery on stopping its administration. The threshold dose of recombinant human relaxin (rhRLX) for renal vasodilation and reduction in plasma osmolality was 0.15 μg/h when given by subcutaneous osmotic minipump for 2 days (an infusion rate that achieved circulating levels of ∼6 ng/ml). The peak response was observed during the 0.4 μg/h infusion rate (serum rhRLX of ∼11 ng/ml), which was comparable to our previous work using a 4.0 μg/h (serum rhRLX of ∼20 ng/ml). In contrast, a dose of 40 μg/h was ineffective (serum rhRLX of ∼80 ng/ml). When 4.0 μg/h rhRLX was administered by osmotic minipump for shorter periods (≤24 h), renal circulatory and osmoregulatory changes were observed by ≤6 h. After removal of the osmotic minipump, these changes persisted for at least 12 h, but they were fully restored by 24 h. Even briefer administration of 4.0 μg/h rhRLX by intravenous infusion showed an onset of action in the kidney by 1-2 h. In contrast, the 40 μg/h dose of rhRLX elicited minimal effects, and comparable to our earlier report, 4.0 μg/h purified porcine relaxin was also relatively ineffective during short-term intravenous administration. In conclusion, the effect of relaxin on the renal circulation and osmoregulation is biphasic, insofar as high doses are relatively inactive, and the onset of action is more rapid than previously believed. These findings may be important to consider when evaluating relaxin in the treatment of renal disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Relaxin family peptides and their receptors
Bathgate, R. A. D., Halls, M. L., van der Westhuizen, E. T., Callander, G. E., Kocan, M., & Summers, R. J. (2013) · Physiological Reviews · doi:10.1152/physrev.00001.2012 · Cited by 534
Teerlink, J. R., Metra, M., Felker, G. M., Ponikowski, P., Voors, A. A., Weatherley, B. D., Marmor, A., Katz, A., Grzybowski, J., Unemori, E., et al. (2009) · The Lancet · doi:10.1016/s0140-6736(09)60622-x · Cited by 423
Cardiovascular effects of relaxin: from basic science to clinical therapy
Du, X.-J., Bathgate, R. A. D., Samuel, C. S., Dart, A. M., & Summers, R. J. (2010) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2009.198 · Cited by 188
Sarwar, M., Samuel, C. S., Bathgate, R. A., Stewart, D. R., & Summers, R. J. (2015) · British Journal of Pharmacology · doi:10.1111/bph.12964 · Cited by 74
“We showed that the bell-shaped CRCs that are a hallmark of serelaxin activity experimentally (Unemori et al., 1996; Danielson and Conrad, 2003; Halls et al., 2006) and clinically (Teerlink et al.”
BackgroundMallart, S., Ingenito, R., Bianchi, E., Bresciani, A., Esposito, S., Gallo, M., Magotti, P., Monteagudo, E., Orsatti, L., Roversi, D., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.0c01533 · Cited by 29
Metadata
- Authors
- Danielson, L. A., & Conrad, K. P.
- Venue
- Journal of Applied Physiology
- Publisher
- American Physiological Society
- Published
- 2003-10
- Volume
- 95
- Issue
- 4
- Pages
- 1509-1514
- ISSN
- 0161-7567 (ISSN-L)
- 8750-7587
- 1522-1601
- OpenAlex
- W2163394653
- Cited by
- 101
- References
- 0
- FWCI
- 7.91
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats. https://app.cochat.ai/papers/10.1152/japplphysiol.00545.2003
- The paper
- Danielson, L. A., & Conrad, K. P. (2003). Time course and dose response of relaxin-mediated renal vasodilation, hyperfiltration, and changes in plasma osmolality in conscious rats. Journal of Applied Physiology. https://doi.org/10.1152/japplphysiol.00545.2003
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.